03 August 2017
Visiongain’ has launched a new pharma report Global ePharmacy Market Report : US, Canada, Mexico, UK, Germany, Italy, France, Spain, Portugal, India, China, Japan, Australia, GCC, Egypt, South Africa
ePharmacy or online pharmacy or internet pharmacy as it is sometimes called is an internet-based service where vendors can sell various pharmaceutical products both legally or illegally. The current report is an estimation of the legal online pharmacy market. Most pharmaceutical chains are trying to have their online portal to help in establishing a global reach for dispensing drugs. The market however is very sensitive owing to the regulations which though are already established in the developed countries of North America and Europe, is still being framed in emerging countries such as India and China.
The lead analyst of this report commented “ePharmacy has been seen for many years as an upcoming and potentially transformative technology. Factors such as the developing regulations of online pharmacy in developing countries, growing economic feasibility, cheap prices of generic drugs and the ease of ordering medicines from home is going to benefit the growth of the market.
However, the industry has many barriers to overcome. Current reimbursement and regulatory systems, threat of illegal pharmacies and increasing risk of drug abuse. In addition, entry of big e-commerce giants like Amazon and Walmart will also pose a threat to the existing market players.”
Leading companies featured in the report include DocMorris, CVS Caremark, Lloyds Pharma
Walgreens Boots Alliance, Pharmacy2U, Rowlands Pharmacy
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.
29 September 2022
The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.
21 September 2022
The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.
16 September 2022
The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.